“Development And In-Vivo Evaluation Of Atorvastatin Solid Lipid Nanoparticles For Anti-Hyperlipidemic Activity” (2025) Journal of Carcinogenesis, 24(8s), pp. 343–351. doi:10.64149/J.Carcinog.24.8s.343-351.